Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial

Background: Lung cancer is the most common cause of cancer related death worldwide. The majority of cases are detected at a late stage when prognosis is poor. The EarlyCDT®-Lung Test detects autoantibodies to abnormal cell surface proteins in the earliest stages of the disease which may allow tumour...

Full description

Bibliographic Details
Main Authors:	Sullivan, Frank M., Farmer, Eoghan, Mair, Frances S., Treweek, Shaun, Kendrick, Denise, Jackson, Cathy, Robertson, Chris, Briggs, Andrew, McCowan, Colin, Bedford, Laura, Young, Ben, Vedhara, Kavita, Gallant, Stephanie, Littleford, Roberta, Robertson, John, Sewell, Herb, Dorward, Alistair, Sarvesvaran, Joseph, Schembri, Stuart
Format:	Article
Published:	BioMed Central 2017
Subjects:	Lung cancer; Early diagnosis; Screening; Health economics; RCT; Primary care; Biomarker; Autoantibodies
Online Access:	https://eprints.nottingham.ac.uk/41357/

Internet

https://eprints.nottingham.ac.uk/41357/

Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial

Internet

Similar Items